MLICM
TNYA icon

Metropolitan Life Insurance Company (MetLife)’s Tenaya Therapeutics TNYA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,776
Closed -$14.5K – 1936
2024
Q1 		$14.5K Buy
+2,776
New +$13.3K ﹤0.01% 2007
2023
Q4 		– Sell
-2,607
Closed -$6.65K – 2388
2023
Q3 		$6.65K Hold
2,607
– – ﹤0.01% 2368
2023
Q2 		$15.3K Buy
+2,607
New +$15.2K ﹤0.01% 2074
2022
Q2 		– Sell
-2,194
Closed -$25.8K – 2431
2022
Q1 		$25.8K Sell
2,194
-2,237
-50% -$27.1K ﹤0.01% 1967
2021
Q4 		$84K Hold
4,431
– – ﹤0.01% 2571
2021
Q3 		$91.5K Buy
+4,431
New +$95.2K ﹤0.01% 2570

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s TNYA Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Tenaya Therapeutics (TNYA) in Q2 2024, closing a stake of 2,776 shares — an estimated $14.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TNYA in Q3 2021 and held it in 6 quarters. The position peaked at $91.5K in Q3 2021. 96 funds tracked by Wall St. Rank hold TNYA as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Tenaya Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,776 Tenaya Therapeutics shares in Q2 2024, an estimated $14.5K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Tenaya Therapeutics in Q3 2021 and held it in 6 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Tenaya Therapeutics position peaked at $91.5K in Q3 2021.
  • 96 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.